Soybean oil is more obesogenic and diabetogenic than coconut oil and fructose in mouse: Potential role for the liver

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Deol, Poonamjot ^a   Evans, Jane R ^a   Dhahbi, Joseph ^b   Chellappa, Karthikeyani ^c   Han, Diana S ^a   Spindler, Stephen ^b   Sladek, Frances M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD63 ANTIGEN; CHOLESTEROL; COCONUT OIL; CYTOCHROME P450 2C; CYTOCHROME P450 3A2; FRUCTOSE; GAMMA TOCOPHEROL; POLYUNSATURATED FATTY ACID; PYRUVATE DEHYDROGENASE KINASE 4; RNA H19; SOMATOMEDIN BINDING PROTEIN 1; SOYBEAN OIL; CYTOCHROME P450; FAT INTAKE; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CD36 GENE; CD63 GENE; CIDEC GENE; CONTROLLED STUDY; CYP2C GENE; CYP3A GENE; DIABETES MELLITUS; FATTY LIVER; GENE; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; H19 GENE; IGFBP1 GENE; INSULIN RESISTANCE; KIDNEY MASS; LIPID DIET; LIVER CELL DAMAGE; MALE; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PDK4 GENE; RECTUM PROLAPSE; SPLEEN WEIGHT; UPREGULATION; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; DRUG EFFECTS; FAT INTAKE; GENETICS; LIVER; METABOLISM; PATHOLOGY;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS; DIETARY FATS; FRUCTOSE; GENE EXPRESSION REGULATION; INSULIN RESISTANCE; LIVER; MALE; MICE; OBESITY; PLANT OILS; SOYBEAN OIL;

EID: 84941312574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132672     Document Type: Article

References (168)

1. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008; 16: 2323-2330.
2. Dobbs R, Sawers C, Thompson F, Manyika J, Woetzel J, Child P, et al. Overcoming obesity: An initial economic analysis. McKinsey Global Institute Report.2014.
3. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384: 766-781. doi:10.1016/S0140-6736(14)60460-8 PMID: 24880830.
4. Obesity and Overweight. 2015 [cited 31 January 2015]. Available: http://www.who.int/mediacentre/factsheets/fs311/en/.
5. O'Neill S, O'Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015; 16: 1-12.
6. Kimura N, Keys A. Coronary heart disease in seven countries. X. Rural southern Japan. Circulation. 1970; 41: 101-112. PMID: 5442775.
7. Keys A. Diet and the epidemiology of coronary heart disease. J Am Med Assoc. 1957; 164: 1912-1919. PMID: 13448947.
8. Page I. H. AEB, Chamberlain F. L., Keys A., Stamler J., Stare F. J. Dietary fat and its relation to heart attacks and strokes. Circulation. 1961; 23: 133-136.
9. Kritchevsky D. History of recommendations to the public about dietary fat. J Nutr. 1998; 128: 449S-452S. PMID: 9478046.
10. Eckel RH, Jakicic JM, Ard JD, de-Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63: 2960-2984. doi:10.1016/j.jacc.2013.11.003 PMID: 24239922.
11. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann Intern Med. 2014; 160: 398-406. doi:10.7326/M13-1788PMID: 24723079.
12. Lamarche B, Couture P. It is time to revisit current dietary recommendations for saturated fat. Appl Physiol Nutr Metab. 2014: 1-3. doi:10.1139/apnm-2013-0026 PMID: 24383502.
13. Xue C, Liu Y, Wang J, Zhang R, Zhang Y, Zhang J, et al. Consumption of medium-and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. 2009; 63: 879-886. doi:10.1038/ejcn.2008.76PMID: 19156155.
14. Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: A meta-analysis of randomized controlled trials. J Acad Nutr Diet. 2015; 115: 249-263. doi:10.1016/j.jand.2014.10.022 PMID: 25636220.
15. Nagao K, Yanagita T. Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010; 61: 208-212. doi:10.1016/j.phrs.2009.11.007PMID: 19931617.
16. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011; 93: 950-962. doi:10.3945/ajcn.110.006643 PMID: 21367944.
17. Rosillo-Calle F. A global overview of vegetable oils, with reference to biodiesel. A Report for the IEA Bioenergy Task 40. 2009.
18. Roccisano D, Henneberg M. Contribution of soy consumption to obesity worldwide. Am J Phys Anthropol. 2011; 144: 255-255.
19. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism. 1996; 45: 1539-1546. PMID: 8969289.
20. Sena CM, Proenca T, Nunes E, Santos MS, Seica RM. The effect of soybean oil on glycaemic control in Goto-kakizaki rats, an animal model of type 2 diabetes. Med Chem. 2008; 4: 293-297. PMID: 18473922.
21. Zhang XH, Hua JZ, Wang SR, Sun CH. Post-weaning isocaloric hyper-soybean oil versus a hypercarbohydrate diet reduces obesity in adult rats induced by a high-fat diet. Asia Pac J Clin Nutr. 2007; 16 Suppl 1: 368-373. PMID: 17392134.
22. Lee KT, Akoh CC, Flatt WP, Lee JH. Nutritional effects of enzymatically modified soybean oil with caprylic acid versus physical mixture analogue in obese Zucker rats. J Agric Food Chem. 2000; 48: 5696-5701. PMID: 11087541.
23. Da-Costa CA, Carlos AS, de Sousa Dos-Santos A, de Moura EG, Nascimento-Saba CC. High-fat diets containing soybean or canola oil affect differently pancreas function of young male rats. Horm Metab Res. 2013; 45: 652-654. doi:10.1055/s-0033-1345150PMID: 23761162.
24. Midtbo LK, Ibrahim MM, Myrmel LS, Aune UL, Alvheim AR, Liland NS, et al. Intake of farmed Atlantic salmon fed soybean oil increases insulin resistance and hepatic lipid accumulation in mice. PLoS One. 2013; 8: e53094doi:10.1371/journal.pone.0053094PMID: 23301026.
25. Costa CA, Carlos AS, dos-Santos Ade S, Monteiro AM, Moura EG, Nascimento-Saba CC. Abdominal adiposity, insulin and bone quality in young male rats fed a high-fat diet containing soybean or canola oil. Clinics (Sao Paulo). 2011; 66: 1811-1816.
26. Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2010; 121: 1356-1364. doi:10.1161/CIRCULATIONAHA.109.876185 PMID: 20308626.
27. Marriott BP, Olsho L, Hadden L, Connor P. Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr. 2010; 50: 228-258. doi:10.1080/10408391003626223 PMID: 20301013.
28. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010; 90: 23-46. doi:10.1152/physrev.00019.2009 PMID: 20086073.
29. Park YK, Yetley EA. Intakes and food sources of fructose in the United States. Am J Clin Nutr. 1993; 58: 737S-747S. PMID: 8213605.
30. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009; 139: 1228S-1235S. doi:10.3945/jn.108.098277 PMID: 19403716.
31. Stanhope KL, Schwarz JM, Havel PJ. Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol. 2013; 24: 198-206. doi:10.1097/MOL.0b013e3283613bcaPMID: 23594708.
32. Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care. 2014; 37: 950-956. doi:10.2337/dc13-2085 PMID: 24652725.
33. Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: we have, but the pox on sugar is overwrought and overworked. Diabetes Care. 2014; 37: 957-962. doi:10.2337/dc13-2506PMID: 24652726.
34. Jurgonski A, Juskiewicz J, Zdunczyk Z. A high-fat diet differentially affects the gut metabolism and blood lipids of rats depending on the type of dietary fat and carbohydrate. Nutrients. 2014; 6: 616-626. doi:10.3390/nu6020616 PMID: 24496299.
35. Cohen E, Cragg M, deFonseka J, Hite A, Rosenberg M, Zhou B. Statistical review of US macronutrient consumption data, 1965-2011: Americans have been following dietary guidelines, coincident with the rise in obesity. Nutrition. 2015; 31: 727-732. doi:10.1016/j.nut.2015.02.007 PMID: 25837220.
36. Ghosh S, Molcan E, Decoffe D, Dai C, Gibson DL. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice. Br J Nutr. 2013; 110: 515-523. doi:10.1017/S0007114512005326 PMID: 23298440.
37. Zhang Z, Gillespie C, Welsh JA, Hu FB, Yang Q. Usual intake of added sugars and lipid profiles among the U.S. adolescents: National Health and Nutrition Examination Survey, 2005-2010. J Adolesc Health. 2015; 56: 352-359. doi: 10.1016/j.jadohealth.2014.12.001 PMID: 25703323.
38. Reeves PG, Nielsen FH, Fahey GC Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993; 123: 1939-1951. PMID: 8229312.
39. Burr GOB, M.M. On the nature and role of the fatty acids essential in nutrition. J Biol Chem. 1930; LXXXVI.
40. Burr GOB, M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem. 1929; LXXXII.
41. Cerecedo LR, Panzarella FP, Vasta AB, De-Renzo EC. Studies on essential fatty acid deficiency in three strains of mice. J Nutr. 1952; 48: 41-47. PMID: 13000490.
42. Clemente TE, Cahoon EB. Soybean oil: genetic approaches for modification of functionality and total content. Plant Physiol. 2009; 151: 1030-1040. doi:10.1104/pp.109.146282PMID: 19783644.
43. Ayala JE, Samuel VT, Morton GJ, Obici S, Croniger CM, Shulman GI, et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech. 2010; 3: 525-534. doi:10.1242/dmm.006239 PMID: 20713647.
44. Haas BJ, Chin M, Nusbaum C, Birren BW, Livny J. How deep is deep enough for RNA-Seq profiling of bacterial transcriptomes? BMC Genomics. 2012; 13: 734. doi:10.1186/1471-2164-13-734 PMID: 23270466.
45. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25: 1105-1111. doi:10.1093/bioinformatics/btp120 PMID: 19289445.
46. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van-Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010; 28: 511-515. doi:10.1038/nbt.1621PMID: 20436464.
47. Huangda W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37: 1-13. doi:10.1093/nar/gkn923 PMID: 19033363.
48. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008; 134: 112-123. doi:10.1016/j.cell.2008.06.016 PMID: 18614015.
49. Oliveros JC. VENNY: An interactive tool for comparing lists with Venn diagrams. 2007.
50. Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PloS One. 2009; 4: e5609. doi:10.1371/journal.pone.0005609 PMID: 19440305.
51. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009; 457: 910-914. doi:10.1038/nature07762 PMID: 19212411.
52. Trumbo P, Schlicker S, Yates AA, Poos M, Food, Nutrition Board of the Institute of Medicine TNA. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102: 1621-1630. PMID: 12449285.
53. Alvheim AR, Torstensen BE, Lin YH, Lillefosse HH, Lock EJ, Madsen L, et al. Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice. Br J Nutr. 2013; 109: 1508-1517. doi:10.1017/S0007114512003364 PMID: 22883314.
54. Nieto G, Ros, G. Modification of Fatty Acid Composition in Meat Through Diet: Effect on Lipid Peroxidation and Relationship to Nutritional Quality-A Review, Lipid Peroxidation, Dr. Angel Catala (Ed.). 2012 [cited Available: http://www.intechopen.com/books/lipid-peroxidation/modification-of-fatty-acidcomposition-in-meat-through-diet-effect-on-lipid-peroxidation-and-relatio.
55. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010; 7: 251-264. doi:10.1038/nrgastro.2010.41PMID: 20368739.
56. Farah V, Elased KM, Chen Y, Key MP, Cunha TS, Irigoyen MC, et al. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci. 2006; 130: 41-50. PMID: 16843071.
57. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 2009; 50: 1094-1104. doi:10.1002/hep.23122 PMID: 19637282.
58. Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol. 1999; 19: 1223-1230. PMID: 10323773.
59. MESJJ J. (2015) Nutrient absorption in the human gastrointestinal tract. In: Cristina Sabilov HC, Rickey Yada, editor. Nanotechonology and Functional Foods: Effective Delivery of Bioactive Ingredients: John Wiley & Sons.
60. McCullogh JS, Ratcliffe B, Mandir N, Carr KE, Goodlad RA. Dietary fibre and intestinal microflora: effects on intestinal morphometry and crypt branching. Gut. 1998; 42: 799-806. PMID: 9691918.
61. Sunter JP, Watson AJ, Wright NA, Appleton DR. Cell proliferation at different sites along the length of the rat colon. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979; 32: 75-87. PMID: 45155.
62. McGarrity TJ, Peiffer LP, Colony PC. Cellular proliferation in proximal and distal rat colon during 1, 2-dimethylhydrazine-induced carcinogenesis. Gastroenterology. 1988; 95: 343-348. PMID: 3391364.
63. van Buul VJ, Tappy L, Brouns FJ. Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr Res Rev. 2014; 27: 119-130. doi:10.1017/S0954422414000067 PMID: 24666553.
64. Jurgens H, Haass W, Castaneda TR, Schurmann A, Koebnick C, Dombrowski F, et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res. 2005; 13: 1146-1156. PMID: 16076983.
65. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, et al. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension. 2005; 45: 1012-1018. PMID: 15824194.
66. Xu L, Zhou L, Li P. CIDE proteins and lipid metabolism. Arterioscler Thromb Vasc Biol. 2012; 32: 1094-1098. doi:10.1161/ATVBAHA.111.241489 PMID: 22517368.
67. Zhou L, Xu L, Ye J, Li D, Wang W, Li X, et al. Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatology. 2012; 56: 95-107. doi:10.1002/hep.25611 PMID: 22278400.
68. Su X, Abumrad NA. Cellular fatty acid uptake: A pathway under construction. Trends Endocrinol Metab. 2009; 20: 72-77. doi:10.1016/j.tem.2008.11.001 PMID: 19185504.
69. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996; 274: 1377-1379. PMID: 8910278.
70. Queipo-Ortuno MI, Escote X, Ceperuelo-Mallafre V, Garrido-Sanchez L, Miranda M, Clemente-Postigo M, et al. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expressionregarding circulating plasma levels. PLoS One. 2012; 7: e48605. doi:10.1371/journal.pone.0048605 PMID: 23139800.
71. Hoekstra M, Stitzinger M, van Wanrooij EJ, Michon IN, Kruijt JK, Kamphorst J, et al. Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res. 2006; 47: 2198-2207. PMID: 16885566.
72. Ooi GT, Tseng LY, Tran MQ, Rechler MM. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol. 1992; 6: 2219-2228. PMID: 1283442.
73. Bacigalupo ML, Manzi M, Rabinovich GA, Troncoso MF. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. World J Gastroenterol. 2013; 19: 8831-8849. doi:10.3748/wjg.v19.i47.8831 PMID: 24379606.
74. Shimonishi T, Miyazaki K, Kono N, Sabit H, Tuneyama K, Harada K, et al. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol. 2001; 32: 302-310. PMID: 11274640.
75. Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, et al. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. J Gastroenterol Hepatol. 2012; 27: 1312-1319. doi:10.1111/j.1440-1746.2012.07130.x PMID: 22432916.
76. Zhang S, Hulver MW, McMillan RP, Cline MA, Gilbert ER. The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr Metab (Lond). 2014; 11: 10.
77. Roat R, Rao V, Doliba NM, Matschinsky FM, Tobias JW, Garcia E, et al. Alterations of pancreatic islet structure, metabolism and gene expression in diet-induced obese C57BL/6J mice. PLoS One. 2014; 9: e86815. doi:10.1371/journal.pone.0086815 PMID: 24505268.
78. Ikeda J, Kaneda S, Kuwabara K, Ogawa S, Kobayashi T, Matsumoto M, et al. Cloning and expression of cDNA encoding the human 150 kDa oxygen-regulated protein, ORP150. Biochem Biophys Res Commun. 1997; 230: 94-99. PMID: 9020069.
79. Haguenauer A, Raimbault S, Masscheleyn S, Gonzalez-Barroso Mdel M, Criscuolo F, Plamondon J, et al. A new renal mitochondrial carrier, KMCP1, is up-regulated during tubular cell regeneration and induction of antioxidant enzymes. J Biol Chem. 2005; 280: 22036-22043. PMID: 15809292.
80. Konig R, Cai P, Guo X, Ansari GA. Transcriptomic analysis reveals early signs of liver toxicity in female MRL +/+ mice exposed to the acylating chemicals dichloroacetyl chloride and dichloroacetic anhydride. Chem Res Toxicol. 2008; 21: 572-582. doi:10.1021/tx7002728 PMID: 18293905.
81. Van-Waterschoot RA, van-Herwaarden AE, Lagas JS, Sparidans RW, Wagenaar E, van-der-Kruijssen CM, et al. Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymes. Mol Pharmacol. 2008; 73: 1029-1036. PMID: 18156313.
82. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006; 439: 484-489. PMID: 16400329.
83. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004; 113: 1408-1418. PMID: 15146238.
84. Ichi I, Kono N, Arita Y, Haga S, Arisawa K, Yamano M, et al. Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency. Biochim Biophys Acta. 2014; 1841: 204-213doi:10.1016/j.bbalip.2013.10.013 PMID: 24184513.
85. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991; 54: 438-463. PMID: 1908631.
86. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res. 2012; 65: 211-222. doi:10.1016/B978-0-12-416003-3.00013-5 PMID: 22361189.
87. De-Roos N, Schouten E, Katan M. Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J Nutr. 2001; 131: 242-245. PMID: 11160540.
88. DeLany JP, Windhauser MM, Champagne CM, Bray GA. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr. 2000; 72: 905-911. PMID: 11010930.
89. Garfinkel M, Lee S, Opara EC, Akwari OE. Insulinotropic potency of lauric acid: A metabolic rationale for medium chain fatty acids (MCF) in TPN formulation. J Surg Res. 1992; 52: 328-333. PMID: 1593871.
90. Lands WE, Morris A, Libelt B. Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids. 1990; 25: 505-516. PMID: 2250586.
91. Fang X, Kaduce TL, Spector AA. 13-(S)-hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells. J Lipid Res. 1999; 40: 699-707. PMID: 10191294.
92. Spector AA, Kim HY. Cytochrome P epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta. 2014.
93. Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004; 43: 55-90. PMID: 14636671.
94. Zha W, Edin ML, Vendrov KC, Schuck RN, Lih FB, Jat JL, et al. Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. J Lipid Res. 2014; 55: 2124-2136. doi:10.1194/jlr.M053199 PMID: 25114171.
95. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem. 2001; 276: 36059-36062. PMID: 11451964.
96. Bieri JG, Evarts RP. Gamma tocopherol: metabolism, biological activity and significance in human vitamin E nutrition. Am J Clin Nutr. 1974; 27: 980-986. PMID: 4472121.
97. Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001; 74: 714-722. PMID: 11722951.
98. Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A. 2004; 101: 17825-17830. PMID: 15596715.
99. Jiang Q, Ames BN. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 2003; 17: 816-822. PMID: 12724340.
100. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, et al. Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013; 178: 38-45. doi:10.1093/aje/kws448 PMID: 23703888.
101. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010; 28: 155-161. doi:10.1159/000282080 PMID: 20460905.
102. Taylor HL, Blackburn H, Keys A, Parlin RW, Vasquez C, Puchner T. Coronary heart disease in seven countries. IV. Five-year follow-up of employees of selected U.S. railroad companies. Circulation. 1970; 41: 20-39. PMID: 5442784.
103. Lockeretz W. Agricultural diversification by crop introduction: The US experience with the soybean. Food Policy. 1988; 13: 154-166.
104. Dulloo AG. The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients. Obes Rev. 2011; 12: 866-883. doi:10.1111/j.1467-789X.2011.00909.x PMID: 21951333.
105. Ogbolu DO, Oni AA, Daini OA, Oloko AP. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food. 2007; 10: 384-387. PMID: 17651080.
106. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape journal of medicine. 2008; 10: 160. PMID: 18769702.
107. Swarbrick MM, Stanhope KL, Elliott SS, Graham JL, Krauss RM, Christiansen MP, et al. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr. 2008; 100: 947-952. doi:10.1017/S0007114508968252 PMID: 18384705.
108. Bray GA. How bad is fructose? Am J Clin Nutr. 2007; 86: 895-896. PMID: 17921361.
109. Bocarsly ME, Powell ES, Avena NM, Hoebel BG. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacology, biochemistry, and behavior. 2010; 97: 101-106. doi:10.1016/j.pbb.2010.02.012 PMID: 20219526.
110. Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr. 2009; 139: 1263S-1268S. doi:10.3945/jn.108.098020 PMID: 19403723.
111. Tappy L, Le KA, Tran C, Paquot N. Fructose and metabolic diseases: new findings, new questions. Nutrition. 2010; 26: 1044-1049. doi:10.1016/j.nut.2010.02.014 PMID: 20471804.
112. Klurfeld DM, Foreyt J, Angelopoulos TJ, Rippe JM. Lack of evidence for high fructose corn syrup as the cause of the obesity epidemic. Int J Obes (Lond). 2012.
113. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008; 48: 993-999. doi:10.1016/j.jhep.2008.02.011 PMID: 18395287.
114. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51: 1961-1971. doi:10.1002/hep.23535 PMID: 20301112.
115. Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism. 2013; 62: 62-69. doi:10.1016/j.metabol.2012.06.008 PMID: 22854109.
116. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010; 52: 934-944. doi:10.1002/hep.23797 PMID: 20607689.
117. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142: 46-54 e42; quiz e30. doi:10.1053/j.gastro.2011.10.001 PMID: 22001864.
118. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009; 29: 2727-2737. PMID: 19596953.
119. Andersson DE, Nygren A. Four cases of long-standing diarrhoea and colic pains cured by fructosefree diet-a pathogenetic discussion. Acta Med Scand. 1978; 203: 87-92. PMID: 626118.
120. Hashimoto Y, Yamada K, Tsushima H, Miyazawa D, Mori M, Nishio K, et al. Three dissimilar high fat diets differentially regulate lipid and glucose metabolism in obesity-resistant Slc:Wistar/ST rats. Lipids. 2013; 48: 803-815. doi:10.1007/s11745-013-3805-3 PMID: 23807365.
121. Lazic M, Inzaugarat ME, Povero D, Zhao IC, Chen M, Nalbandian M, et al. Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis. PLoS One. 2014; 9: e107658. doi:10.1371/journal.pone.0107658 PMID: 25251155.
122. Jeoung NH, Harris RA. Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J. 2010; 34: 274-283. doi:10.4093/kdj.2010.34.5.274PMID: 21076574.
123. Hwang B, Jeoung NH, Harris RA. Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet. Biochem J. 2009; 423: 243-252. doi:10.1042/BJ20090390 PMID: 19627255.
124. Tao R, Xiong X, Harris RA, White MF, Dong XC. Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes. PLoS One. 2013; 8: e71997. doi:10.1371/journal.pone.0071997 PMID: 23940800.
125. Gong J, Sun Z, Li P. CIDE proteins and metabolic disorders. Curr Opin Lipidol. 2009; 20: 121-126. doi:10.1097/MOL.0b013e328328d0bb PMID: 19276890.
126. Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011; 121: 2102-2110. doi:10.1172/JCI46069 PMID: 21633178.
127. Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, Chouinard M, et al. Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem. 2007; 282: 34213-34218. PMID: 17884815.
128. Bickel PE, Tansey JT, Welte MA. PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta. 2009; 1791: 419-440. doi10.1016/j.bbalip.2009.04.002 PMID: 19375517.
129. Krahmer N, Farese RV Jr., Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med. 2013; 5: 905-915. doi:10.1002/emmm.201100671 PMID: 23740690.
130. Zhou Z, Yon Toh S, Chen Z, Guo K, Ng CP, Ponniah S, et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet. 2003; 35: 49-56.
131. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest. 2008; 118: 2808-2821. doi:10.1172/JCI34090 PMID: 18654663.
132. Yang H, Galea A, Sytnyk V, Crossley M. Controlling the size of lipid droplets: lipid and protein factors. Curr Opin Cell Biol. 2012; 24: 509-516. doi:10.1016/j.ceb.2012.05.012 PMID: 22726586.
133. Schaefer EJ, Gleason JA, Dansinger ML. Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr. 2009; 139: 1257S-1262S. doi:10.3945/jn.108.098186 PMID: 19403705.
134. Yarmishyn AA, Kurochkin IV. Long noncoding RNAs: A potential novel class of cancer biomarkers. Front Genet. 2015; 6: 145. doi:10.3389/fgene.2015.00145 PMID: 25954300.
135. Campion J, Milagro FI, Martinez JA. Individuality and epigenetics in obesity. Obes Rev. 2009; 10: 383-392. doi:10.1111/j.1467-789X.2009.00595.xPMID: 19413700.
136. Dudley KJ, Sloboda DM, Connor KL, Beltrand J, Vickers MH. Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. PLoS One. 2011; 6: e21662. doi:10.1371/journal.pone.0021662 PMID: 21779332.
137. Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21 (CDKN1A) in the DNA damage response. Mutat Res. 2010; 704: 12-20. doi:10.1016/j.mrrev.201001.009 PMID: 20096807.
138. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75: 817-825. PMID: 8242752.
139. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009; 9: 400-414. doi:10.1038/nrc2657 PMID: 19440234.
140. Reebye V, Saetrom P, Mintz PJ, Huang KW, Swiderski P, Peng L, et al. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. Hepatology. 2014; 59: 216-227. doi:10.1002/hep.26669 PMID: 23929703.
141. Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WC. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids. 2009; 81: 391-399. doi:10.1016/j.plefa.2009.08.003 PMID: 19782547.
142. Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res. 2013; 73: 4722-4731. doi:10.1158/0008-5472.CAN-12-3797 PMID: 23749645.
143. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: A meta-analysis of cohort studies. Br J Cancer. 2007; 97: 1005-1008. PMID: 17700568.
144. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29. doi:10.3322/caac.21208 PMID: 24399786.
145. Howlader N NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD. 2014 [cited 31 January 2015]. Available: http://seer.cancer.gov/csr/1975-2011/.
146. Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity. 2012; 20: 1984-1994. doi:10.1038/oby.2012.38 PMID: 22334255.
147. Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: A systematic review. Nutr Metab (Lond). 2011; 8: 36.
148. Ulbricht TL, Southgate DA. Coronary heart disease: seven dietary factors. Lancet. 1991; 338: 985-992. PMID: 1681350.
149. Sanders TA. Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials. Proc Nutr Soc. 2014; 73: 73-79. doi:10.1017/S0029665113003789PMID: 24308351.
150. Aravanis C, Corcondilas A, Dontas AS, Lekos D, Keys A. Coronary heart disease in seven countries. IX. The Greek islands of Crete and Corfu. Circulation. 1970; 41: 88-100. PMID: 5442787.
151. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4: 44-57. doi:10.1038/nprot.2008.211 PMID: 19131956.
152. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006; 7: 885-896. PMID: 17139329.
153. Tontonoz P, Spiegelman BM. Fat and beyond: The diverse biology of PPARgamma. Annu Rev Biochem. 2008; 77: 289-312. doi:10.1146/annurev.biochem.77.061307.091829 PMID: 18518822.
154. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest. 1996; 97: 2553-2561. PMID: 8647948.
155. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol. 2001; 21: 1393-1403. PMID: 11158324.
156. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996; 384: 458-460. PMID: 8945471.
157. Hwang-Verslues WW, Sladek FM. HNF4alpha-role in drug metabolism and potential drug target? Curr Opin Pharmacol. 2010; 10: 698-705. doi:10.1016/j.coph.2010.08.010 PMID: 20833107.
158. Fang B, Mane-Padros D, Bolotin E, Jiang T, Sladek FM. Identification of a binding motif specific to HNF4 by comparative analysis ofmultiple nuclear receptors. Nucleic Acids Res. 2012; 40: 5343-5356. doi:10.1093/nar/gks190 PMID: 22383578.
159. Ma K, Zhang Y, Elam MB, Cook GA, Park EA. Cloning of the rat pyruvate dehydrogenase kinase 4 gene promoter: Activation of pyruvate dehydrogenase kinase 4 by the peroxisome proliferatoractivated receptor gamma coactivator. J Biol Chem. 2005; 280: 29525-29532. PMID: 15967803.
160. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, et al. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology. 2010; 51: 642-653. doi:10.1002/hep.23357 PMID: 20054869.
161. Watt AJ, Garrison WD, Duncan SA. HNF4: A central regulator of hepatocyte differentiation and function. Hepatology. 2003; 37: 1249-1253. PMID: 12774000.
162. Rogue A, Spire C, Brun M, Claude N, Guillouzo A. Gene expression changes induced by PPAR gamma agonists in animal and human liver. PPAR Res. 2010; 2010: 325183. doi:10.1155/2010/325183PMID: 20981297.
163. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem. 2003; 278: 498-505. PMID: 12401792.
164. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003; 300: 472-476. PMID: 12504108.
165. Dayton S, Hashimoto S, Dixon W, Pearce ML. Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res. 1966; 7: 103-111. PMID: 5900208.
166. Massiera F, Barbry P, Guesnet P, Joly A, Luquet S, Moreilhon-Brest C, et al. A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res. 2010; 51: 2352-2361. doi:10.1194/jlr.M006866 PMID: 20410018.
167. Madsen L, Pedersen LM, Liaset B, Ma T, Petersen RK, van-den-Berg S, et al. cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem. 2008; 283: 7196-7205. PMID: 18070879.
168. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010; 29: 289S-301S. PMID: 20823489.